Professor, Psychiatry, UCSD School of Medicine
Psychiatry
Dr. David Feifel, MD
|
|
Give Review
David Feifel practices Psychiatry. He over the years received 1 awards: "Regional Top Doctor". David Feifel is a published doctor. He published 100 publications, including: 'Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Antipsychotic drug-like facilitation of latent inhibition by a brain-penetrating neurotensin-1 receptor agonist.
- A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.
- Potential of Oxytocin in the Treatment of Schizophrenia.
- Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs.
- A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for Adults wit...
- Oxytocin׳s role in Anxiety: A critical appraisal.
- Developing Research Domain Criteria (RDoC) to improve diagnosis and treatment of social Deficits in psychiatric disorders: The Mirror Neuron System as a model.
- Not disappointed by Anxiety: A reply to Cardoso and Ellenbogen's commentary "Oxytocin and psychotherapy: Keeping context and person in mind"
- Intramuscular Ziprasidone: Influence of Alcohol and Benzodiazepines on Vital Signs in the Emergency Setting.
- Limited evidence that benzodiazepines are beneficial in the treatment of disturbed behaviour.
- Oxytocin and psychotherapy: A pilot study of its physiological, behavioral and subjective effects in males with depression.
- The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.
- Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain Disorders.
- In reply:.
- A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation.
- Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.
- Oxytocin in Schizophrenia: a review of evidence for its therapeutic effects.
- The effects of oxytocin and its analog, carbetocin, on genetic Deficits in sensorimotor gating.
- A Naturalistic Study of Intramuscular Haloperidol Versus Intramuscular Olanzapine for the Management of Acute Agitation.
- Dramatic Improvement in Sexual Function Induced by Intranasal Oxytocin.
- Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A r...
- Vasopressin-deficient rats exhibit sensorimotor gating Deficits that are reversed by subchronic haloperidol.
- Sensorimotor gating Deficits in bipolar disorder patients with acute psychotic mania.
- Startle and sensorimotor gating in rats lacking CCK-A receptors.
- Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.
- Rationale and guidelines for the inpatient treatment of acute psychosis.
- Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
- Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle.
- Individual differences in prepulse inhibition of startle as a measure of individual dopamine function.
- The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating.
- Attitudes toward psychiatry as a prospective career among students entering medical school.
- Oxytocin modulates psychotomimetic-induced Deficits in sensorimotor gating.
- Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
- Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
- Pro-dopamine effects of neurotensin on sensorimotor gating Deficits.
- Parallels of psychoanalytic theory and quantum mechanics.
- Cysteamine blocks amphetamine-induced Deficits in sensorimotor gating.
- The effects of intra-accumbens neurotensin on sensorimotor gating.
- The modulation of sensorimotor gating Deficits by mesolimbic cholecystokinin.
- Iron overload among a psychiatric outpatient population.
- Attention-deficit hyperactivity disorder in Adults.
- Intraventricular but not intraparaventricular nucleus metergoline elicits feeding in satiated rats.
- Evidence for a common neural mechanism mediating growth hormone-releasing factor-induced and somatostatin-induced feeding.
- Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: a model for the integration of central and peripheral function.
- Blockade of endogenous GRF at dark onset selectively suppresses protein intake.
- Centrally administered hypothalamic growth hormone-releasing factor stimulates food intake in free-feeding rats.
- Feeding effects of growth hormone-releasing factor in rats are photoperiod sensitive.
- Central injections of growth hormone-releasing factor increase operant responding for food reward.
- Central somatostatin: a re-examination of its effects on feeding.
- Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats.
- The brattleboro rat displays a natural Deficit in social discrimination that is restored by clozapine and a neurotensin analog.
- Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.
- SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition Deficits produced by dizocilpine and DOI.
- Neurotensin agonists block the prepulse inhibition Deficits produced by a 5-HT2A and an alpha1 agonist.
- The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
- Sensorimotor gating in neurotensin-1 receptor null mice.
- Oxytocin as a potential therapeutic target for Schizophrenia and other neuropsychiatric conditions.
- Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in Adults with attention-deficit/hyperactivity disorder: a randomized, double...
- Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.
- A Naturalistic, Single-blind Comparison of Rapid Dose Administration of Divalproex ER Versus Quetiapine in Patients with Acute Bipolar Mania.
- Is oxytocin a promising treatment for Schizophrenia?
- Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with Schizophrenia: a randomized, double-blind, placebo-controlled trial.
- Rapid acute treatment of agitation in individuals with Schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
- The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature.
- Extended release quetiapine fumarate monotherapy in major depressive Disorder: a placebo- and duloxetine-controlled study.
- A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist.
- Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lo...
- Reversal of sensorimotor gating Deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictiv...
- Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats.
- Information processing Deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.
- Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
- Recent changes in prescriptions for antipsychotics in children and adolescents.
- When common clinical practice meets evidence-based medicine.
- Time to feel good: the therapeutic time course of antidepressants.
- Strattera: ups, downs, and emerging uses.
- A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.
- Adjunctive intranasal oxytocin reduces symptoms in Schizophrenia patients.
- Promise and pitfalls of animal models of Schizophrenia.
- An atomoxetine tutorial.
- ADHD in Adults: the invisible rhinoceros.
- Daytrana: the first year.
- Effects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activity.
- The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II-Ethical Considerations Related to the Individual Participant.
- The Psychiatric Emergency Research Collaboration-01: methods and results.
- More depressing news on antidepressants: should we panic?
- Treatment of autistic children.
- Use of risperidone long-acting injectable in a rural border community clinic in southern california.
- Transforming the psychiatric inpatient unit from short-term pseudo-asylum care to state-of-the-art treatment setting.
- The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I-statistics and the case for the "greater good".
- Attention-deficit/hyperactivity disorder in Adults: recognition and diagnosis of this often-overlooked condition.
- Commentary: why diagnose and treat ADHD in Adults?
- Prepulse inhibition of startle in Adults with ADHD.
- The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.
- The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
- Dosing of divalproex extended release.
- The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition Deficits in Brattleboro rats.
- The effects of cross-fostering on inherent sensorimotor gating Deficits exhibited by Brattleboro rats.
- The relationship between sensorimotor gating and clinical improvement in acutely ill Schizophrenia patients.
- Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition Deficits.
Schools
University Of Toronto Faculty Of Medicine
Toronto General Hosptial
University Of California San Diego Medical Center
University Of Toronto
Procedures Preformed
- Psychiatric Evaluation
- Transcranial Magnetic Stimulation (TMS)
Conditions Treated
- Adult Attention Deficit Hyperactivity Disorder (ADHD)
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Major Depressive Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of California San Diego -
University of Toronto Faculty of Medicine
Hospital
-
UC San Diego Health -
Rady Children's Hospital - San Diego
Drug Facts
| NPI NUMBER | 1053467738 | |
| NPPES Provider LastName | FEIFEL | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 921038620 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 116.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053467738 |
| Last Name Of The Provider | FEIFEL |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. David S. Janowsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Becker, MD |
|
|
Dr. John R. Aldous, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor Grant, MD |
|
|
Dr. Michael W. Kiang, MD |
|
|
Dr. Morton S. Jacobs, MD |
|
|
Dr. Martin P. Paulus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie L. Chen, OD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristine B. Glass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas P. Kempf, MD |
|
|
Dr. Manjusha V. Ilapakurti, MD |
|
|
Dr. Mario L. Salguero, MD |